Braunstein Scott
Insider CIK 1643875 · ZIOP Director · MRNS Executive Chairman, Director · TARA Director · PCRX SVP, Strategy & Corp. Dev. · TRVN Director · CNST Director · ESPR Director · CRBU Director · RAPT Director · ATAI Director · ATAI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ATAI AtaiBeckley Inc. | D To issuer deriv | 2026-09-11 | 2026-09-11 | 56,818 | — | $0 | 0 | SEC↗ |
| ATAI AtaiBeckley Inc. | D To issuer deriv | 2026-09-11 | 2026-09-11 | 208,063 | — | $0 | 0 | SEC↗ |
| ATAI AtaiBeckley Inc. | D To issuer deriv | 2026-09-11 | 2026-09-11 | 103,000 | — | $0 | 0 | SEC↗ |
| ATAI AtaiBeckley Inc. | D To issuer deriv | 2026-09-11 | 2026-09-11 | 206,000 | — | $0 | 0 | SEC↗ |
| ATAI AtaiBeckley Inc. | D To issuer deriv | 2026-09-11 | 2026-09-11 | 208,063 | — | — | 0 | SEC↗ |
| ATAI AtaiBeckley Inc. | D To issuer deriv | 2026-09-11 | 2026-09-11 | 56,818 | — | — | 0 | SEC↗ |
| ATAI AtaiBeckley Inc. | D To issuer deriv | 2026-09-11 | 2026-09-11 | 103,000 | — | — | 0 | SEC↗ |
| ATAI AtaiBeckley Inc. | D To issuer deriv | 2026-09-11 | 2026-09-11 | 206,000 | — | — | 0 | SEC↗ |
| ATAI AtaiBeckley Inc. | A Award deriv | 2026-06-04 | 2026-06-08 | 121,968 | — | $0 | 121,968 | SEC↗ |
| ATAI AtaiBeckley Inc. | A Award deriv | 2026-06-04 | 2026-06-08 | 86,095 | — | $0 | 86,095 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | D To issuer deriv | 2026-03-03 | 2026-03-05 | 25,000 | — | $0 | 0 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | U Tender | 2026-03-03 | 2026-03-05 | 4,956 | — | $0 | 0 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | A Award deriv | 2026-02-20 | 2026-02-20 | 45,000 | — | $0 | 45,000 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award | 2026-01-30 | 2026-02-02 | 4,956 | — | $0 | 4,956 | SEC↗ |
| ATAI Atai Beckley N.V. | A Award deriv | 2025-11-04 | 2025-11-06 | 56,818 | — | $0 | 56,818 | SEC↗ |
| ATAI ATAI Life Sciences N.V. | A Award deriv | 2025-06-26 | 2025-06-27 | 103,000 | — | $0 | 103,000 | SEC↗ |
| RAPT RAPT Therapeutics, Inc. | A Award deriv | 2025-06-21 | 2025-06-24 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | A Award deriv | 2025-02-20 | 2025-02-21 | 40,500 | — | $0 | 40,500 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 360,000 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 335,650 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 167,825 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 7,500 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 15,917 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 200,000 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 450,000 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 290,000 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer deriv | 2025-02-11 | 2025-02-11 | 193,050 | — | $0 | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer | 2025-02-11 | 2025-02-11 | 179,536 | $0.55 | $98.7K | 0 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | D To issuer | 2025-02-07 | 2025-02-11 | 125,064 | $0.55 | $68.8K | 179,536 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | P Buy | 2024-08-14 | 2025-02-11 | 5,933 | $1.10 | $6.5K | 304,600 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | S Sale | 2024-08-05 | 2024-08-07 | 12,145 | $1.13 | $13.7K | 298,667 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award deriv | 2024-06-18 | 2024-06-20 | 167,825 | — | $0 | 167,825 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award | 2024-06-18 | 2024-06-20 | 37,300 | — | $0 | 310,812 | SEC↗ |
| ATAI ATAI Life Sciences N.V. | A Award deriv | 2024-06-13 | 2024-06-14 | 206,000 | — | $0 | 206,000 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2024-06-13 | 2024-06-17 | 13,700 | — | $0 | 13,700 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | M Exercise deriv | 2024-03-27 | 2024-03-27 | 50,000 | — | $0 | 200,000 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | M Exercise | 2024-03-27 | 2024-03-27 | 50,000 | $4.28 | $214.0K | 273,512 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | A Award deriv | 2024-02-20 | 2024-02-22 | 39,500 | — | $0 | 39,500 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | S Sale | 2024-02-16 | 2024-02-21 | 11,850 | $9.94 | $117.8K | 223,512 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award deriv | 2024-01-18 | 2024-01-19 | 335,650 | — | $0 | 335,650 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award | 2024-01-18 | 2024-01-19 | 74,600 | — | $0 | 235,362 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | S Sale | 2023-08-08 | 2023-08-08 | 30 | $8.94 | $268 | 160,762 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | S Sale | 2023-08-07 | 2023-08-08 | 6,413 | $9.55 | $61.2K | 160,792 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2023-06-15 | 2023-06-20 | 13,700 | — | $0 | 13,700 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | A Award deriv | 2023-02-21 | 2023-02-23 | 21,500 | — | $0 | 21,500 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award deriv | 2023-01-26 | 2023-01-30 | 360,000 | — | $0 | 360,000 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award | 2023-01-26 | 2023-01-30 | 80,000 | — | $0 | 167,205 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2022-06-09 | 2022-06-13 | 100,000 | — | $0 | 100,000 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS, I | A Award | 2022-05-24 | 2022-05-26 | 19,305 | — | $0 | 87,205 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2022-02-04 | 2022-02-07 | 193,050 | — | $0 | 193,050 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award | 2022-02-04 | 2022-02-07 | 42,900 | — | $0 | 67,900 | SEC↗ |
| CRBU Caribou Biosciences, Inc. | A Award deriv | 2021-12-20 | 2021-12-21 | 27,500 | — | $0 | 27,500 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | D To issuer deriv | 2021-07-15 | 2021-07-19 | 13,171 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | D To issuer deriv | 2021-07-15 | 2021-07-19 | 26,342 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | D To issuer deriv | 2021-07-15 | 2021-07-19 | 13,171 | — | $0 | 0 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | A Award deriv | 2021-06-02 | 2021-06-04 | 13,171 | — | $0 | 13,171 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2021-05-28 | 2021-06-02 | 68,577 | — | $0 | 68,577 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2021-01-15 | 2021-01-19 | 290,000 | — | $0 | 290,000 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2020-06-09 | 2020-06-11 | 9,000 | — | $0 | 9,000 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | A Award deriv | 2020-06-04 | 2020-06-08 | 13,171 | — | $0 | 13,171 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2020-05-13 | 2020-05-15 | 64,103 | — | $0 | 64,103 | SEC↗ |
| TARA ArTara Therapeutics, Inc. | A Award | 2020-01-10 | 2020-01-13 | 26,500 | — | $0 | 26,500 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2020-01-09 | 2020-06-11 | 16,214 | — | $0 | 16,214 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2020-01-09 | 2020-06-11 | 15,641 | — | $0 | 15,641 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2020-01-09 | 2020-06-11 | 2,861 | — | $0 | 2,861 | SEC↗ |
| TARA ArTara Therapeutics, Inc. | A Award deriv | 2020-01-09 | 2020-01-13 | 2,861 | — | $0 | 2,861 | SEC↗ |
| TARA ArTara Therapeutics, Inc. | A Award deriv | 2020-01-09 | 2020-01-13 | 9,537 | — | $0 | 9,537 | SEC↗ |
| TARA ArTara Therapeutics, Inc. | A Award deriv | 2020-01-09 | 2020-01-13 | 9,537 | — | $0 | 9,537 | SEC↗ |
| TARA ArTara Therapeutics, Inc. | A Award deriv | 2020-01-09 | 2020-01-13 | 6,676 | — | $0 | 6,676 | SEC↗ |
| TARA ArTara Therapeutics, Inc. | A Award deriv | 2020-01-09 | 2020-01-13 | 15,737 | — | $0 | 15,737 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2020-01-08 | 2020-01-10 | 1,800,000 | — | $0 | 1,800,000 | SEC↗ |
| ZIOP ZIOPHARM ONCOLOGY INC | A Award | 2019-12-31 | 2020-01-03 | 31,780 | — | $0 | 31,780 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | P Buy | 2019-12-13 | 2019-12-13 | 100,000 | $1.25 | $125.0K | 100,000 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2019-08-06 | 2019-08-08 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award | 2019-05-29 | 2019-05-31 | 4,967 | — | $0 | 5,019 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2019-05-16 | 2019-05-16 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MRNS MARINUS PHARMACEUTICALS IN | A Award deriv | 2019-02-26 | 2019-02-28 | 240,000 | — | $0 | 240,000 | SEC↗ |
| CNST CONSTELLATION PHARMACEUTIC | A Award deriv | 2019-02-19 | 2019-02-20 | 26,342 | — | $0 | 26,342 | SEC↗ |
| ZIOP ZIOPHARM ONCOLOGY INC | A Award deriv | 2018-12-31 | 2019-01-02 | 126,700 | — | $0 | 126,700 | SEC↗ |
| TRVN TREVENA INC | A Award deriv | 2018-09-27 | 2018-10-01 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ZIOP ZIOPHARM ONCOLOGY INC | A Award deriv | 2018-09-18 | 2018-09-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2018-05-23 | 2018-05-25 | 10,100 | — | $0 | 10,100 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2018-01-03 | 2018-01-05 | 60,000 | — | $0 | 60,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2017-06-14 | 2017-06-16 | 22,000 | — | $0 | 22,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award | 2017-06-14 | 2017-06-16 | 11,000 | — | $0 | 20,982 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | S Sale | 2017-06-05 | 2017-06-07 | 768 | $43.32 | $33.3K | 9,982 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2017-06-02 | 2017-06-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2017-04-17 | 2017-04-19 | 14,000 | — | $0 | 14,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2016-12-07 | 2016-12-09 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2016-06-15 | 2016-06-17 | 17,500 | — | $0 | 17,500 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award | 2016-06-15 | 2016-06-17 | 8,750 | — | $0 | 10,750 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2016-06-09 | 2016-06-10 | 8,000 | — | $0 | 8,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | P Buy | 2016-01-29 | 2016-02-01 | 2,000 | $58.92 | $117.8K | 2,000 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | A Award deriv | 2015-08-19 | 2015-08-21 | 20,000 | — | $0 | 20,000 | SEC↗ |
| PCRX Pacira Pharmaceuticals, In | A Award deriv | 2015-07-13 | 2015-07-15 | 75,000 | — | $0 | 75,000 | SEC↗ |